Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYALURONIDASE Cause Psoriatic arthropathy? 230 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 230 reports of Psoriatic arthropathy have been filed in association with HYALURONIDASE (Phesgo). This represents 20.8% of all adverse event reports for HYALURONIDASE.

230
Reports of Psoriatic arthropathy with HYALURONIDASE
20.8%
of all HYALURONIDASE reports
194
Deaths
218
Hospitalizations

How Dangerous Is Psoriatic arthropathy From HYALURONIDASE?

Of the 230 reports, 194 (84.3%) resulted in death, 218 (94.8%) required hospitalization, and 218 (94.8%) were considered life-threatening.

Is Psoriatic arthropathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYALURONIDASE. However, 230 reports have been filed with the FAERS database.

What Other Side Effects Does HYALURONIDASE Cause?

Fatigue (375) Alopecia (358) Abdominal discomfort (355) Arthralgia (349) Diarrhoea (330) Headache (328) Hypertension (325) Blood cholesterol increased (320) Arthropathy (318) Off label use (315)

What Other Drugs Cause Psoriatic arthropathy?

SECUKINUMAB (8,900) ADALIMUMAB (8,148) METHOTREXATE (7,167) APREMILAST (7,035) ETANERCEPT (6,518) CERTOLIZUMAB PEGOL (5,798) LEFLUNOMIDE (4,703) INFLIXIMAB (4,238) GOLIMUMAB (4,101) SULFASALAZINE (3,961)

Which HYALURONIDASE Alternatives Have Lower Psoriatic arthropathy Risk?

HYALURONIDASE vs HYALURONIDASE-OCSQ\OCRELIZUMAB HYALURONIDASE vs HYALURONIDASE \RITUXIMAB HYALURONIDASE vs HYALURONIDASE-ZZXF\PERTUZUMAB\TRASTUZUMAB HYALURONIDASE vs HYDRALAZINE HYALURONIDASE vs HYDRALAZINE\ISOSORBIDE DINITRATE

Related Pages

HYALURONIDASE Full Profile All Psoriatic arthropathy Reports All Drugs Causing Psoriatic arthropathy HYALURONIDASE Demographics